Michael Pepoy
Impact in
- Clinical Biochemistry top 2%
- Paraoxonase enzyme and polymorphisms
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Acute Myocardial Infarction Research 3
- Cardiac electrophysiology and arrhythmias 1
-
- Apelin-related biomedical research 3
- Co-authors
- Frederick Van Lente (4 shared papers)Ellen McErlean (2 shared papers)Marlene Goormastic (2 shared papers)Eric J. Topol (2 shared papers)Vijay Nambi (2 shared papers)Stanley L. Hazen (2 shared papers)Marc S. Penn (2 shared papers)Ronnier J. Aviles (2 shared papers)
- Journals
- Journal of the American Heart Association (2 papers)Clinical Journal of the American Society of Nephrology (1 paper)Circulation Heart Failure (1 paper)Clinical Chemistry (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- United StatesPakistan
In The Last Decade
Michael Pepoy
9 papers receiving 1.1k citations
Michael Pepoy's Hit Papers
Peers
Comparison fields: 5 of 99
- Clinical Biochemistry 159
- Immunology 422
- Cardiology and Cardiovascular Medicine 388
- Nephrology 60
- Biochemistry 50
Countries citing papers authored by Michael Pepoy
This map shows the geographic impact of Michael Pepoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pepoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pepoy more than expected).
Fields of papers citing papers by Michael Pepoy
This network shows the impact of papers produced by Michael Pepoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pepoy. The network helps show where Michael Pepoy may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Pepoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Value of Myeloperoxidase in Patients with Chest Pain Hit paper breakdown → | 2003 | 796 |
| 2 | 2004 | 91 | |
| 3 | 2013 | 63 | |
| 4 | 2010 | 56 | |
| 5 | 2013 | 41 | |
| 6 | 1990 | 28 | |
| 7 | 2009 | 24 | |
| 8 | 2013 | 20 | |
| 9 | 2005 | 10 |
About Michael Pepoy
Michael Pepoy is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology, Clinical Biochemistry, Physiology and Immunology, having authored 9 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Paraoxonase enzyme and polymorphisms (3 papers), Apelin-related biomedical research (3 papers), Nitric Oxide and Endothelin Effects (3 papers), Acute Myocardial Infarction Research (3 papers), Cynara cardunculus studies (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). The work is most often cited by research in Clinical Biochemistry (159 citations), Immunology (422 citations), Cardiology and Cardiovascular Medicine (388 citations), Nephrology (60 citations) and Biochemistry (50 citations). Michael Pepoy has collaborated with scholars based in United States and Pakistan. Frequent co-authors include Frederick Van Lente, Ellen McErlean, Marlene Goormastic, Eric J. Topol, Vijay Nambi, Stanley L. Hazen, Marc S. Penn, Ronnier J. Aviles, Marie‐Luise Brennan and Steven E. Nissen. Their work appears in journals such as Journal of the American Heart Association, Clinical Journal of the American Society of Nephrology, Circulation Heart Failure, Clinical Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.